AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Ivanova, LV Rudolph, P Shilov, YM Gieseler, F Alm, P Tareeva, IE Proppe, D
Citation: Lv. Ivanova et al., Correlation between the expression of DNA topoisomerases I and II alpha and clinical parameters in kidney disease, AM J KIDNEY, 38(5), 2001, pp. 1026-1037

Authors: Gieseler, F Clark, M Stiebeling, K Puschmann, M Valsamas, S
Citation: F. Gieseler et al., Pharmacokinetics of idarubicin: Intracellular events and extracellular concentrations, HEMAT BLOOD, 40, 2001, pp. 179-183

Authors: Gieseler, F Clark, M Stiebeling, K Puschmann, M Valsamas, S
Citation: F. Gieseler et al., Induction of apoptosis by idarubicin: how important is the plasma peak?, INT J CL PH, 38(4), 2000, pp. 217-221

Authors: Gieseler, F
Citation: F. Gieseler, The dilemma of gastroenterological oncology: we know a lot but we still achieve too little, INT J COL R, 15(2), 2000, pp. 112-113

Authors: Kurz, EU Leader, KB Kroll, DJ Clark, M Gieseler, F
Citation: Eu. Kurz et al., Modulation of human DNA topoisomerase II alpha function by interaction with 14-3-3 epsilon, J BIOL CHEM, 275(18), 2000, pp. 13948-13954

Authors: Gieseler, F Nuessler, V
Citation: F. Gieseler et V. Nuessler, Apoptosis research is saving the reputation of chemotherapy - Introduction, LEUKEMIA, 13(11), 1999, pp. 1853-1853

Authors: Gieseler, F Bauer, E Nuessler, V Clark, M Valsamas, S
Citation: F. Gieseler et al., Molecular effects of topoisomerase II inhibitors in AML cell lines: correlation of apoptosis with topoisomerase II activity but not with DNA damage, LEUKEMIA, 13(11), 1999, pp. 1859-1863

Authors: Nuessler, V Stotzer, O Gullis, E Pelka-Fleischer, R Pogrebniak, A Gieseler, F Wilmanns, W
Citation: V. Nuessler et al., Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemiacell lines, LEUKEMIA, 13(11), 1999, pp. 1864-1872

Authors: Stopper, H Boos, G Clark, M Gieseler, F
Citation: H. Stopper et al., Are topoisomerase II inhibitor-induced micronuclei in vitro a predictive marker for the compounds' ability to cause secondary leukemias after treatment?, TOX LETT, 104(1-2), 1999, pp. 103-110

Authors: Kessel, M Gieseler, F Woodcock, BG
Citation: M. Kessel et al., Influence of serum protein binding on the uptake and retention of idarubicin by sensitive and multidrug resistant human leukemic cells, EUR J CL PH, 55(5), 1999, pp. 369-373

Authors: Nussler, V Pelka-Fleisc, R Gieseler, F Hasmann, M Loser, R Gullis, E Stotzer, O Zwierzina, H Wilmanns, W
Citation: V. Nussler et al., In vitro efficacy of known P-glycoprotein modulators compared to droloxifene E and Z: Studies on a human T-cell leukemia cell line and their resistant variants, LEUK LYMPH, 31(5-6), 1998, pp. 589-597
Risultati: 1-11 |